A randomized double blinded, 2 arm, multicenter, phase II study of ORA101 in combination with Cisplatin / Vinorelbine versus Cisplatin / Vinorelbine alone, in patients with advanced or recurrent non-small cell lung cancer, who have not received prior chemotherapy
Phase of Trial: Phase II
Latest Information Update: 22 Feb 2007
At a glance
- Drugs Cisplatin; Disulfiram; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 22 Feb 2007 New trial record.